Modification of H3K27me3 in the promoter region of the CDKN2A-2B gene cluster and enrichment of EZH2 were reduced, which increased mRNA levels of the tumor-suppressor genes P14, P15, and P16 and inhibited HCC cell proliferation and migration [87]. The gene discussed is CDKN2A; the disease is neoplasm.